Free Trial

CI Canadian Convertible Bond ETF Common (CXF) Competitors

CI Canadian Convertible Bond ETF Common logo
C$9.85 -0.03 (-0.30%)
As of 04/25/2025 01:37 PM Eastern

CXF vs. IPA, FRX, APM, ITH, GXE, CRDL, GPH, MDNA, EQ, and WMD

Should you be buying CI Canadian Convertible Bond ETF Common stock or one of its competitors? The main competitors of CI Canadian Convertible Bond ETF Common include ImmunoPrecise Antibodies (IPA), Fennec Pharmaceuticals (FRX), Andean Precious Metals (APM), International Tower Hill Mines (ITH), Gear Energy (GXE), Cardiol Therapeutics (CRDL), Graphite One (GPH), Medicenna Therapeutics (MDNA), EQ (EQ), and WeedMD (WMD). These companies are all part of the "pharmaceutical products" industry.

CI Canadian Convertible Bond ETF Common vs.

CI Canadian Convertible Bond ETF Common (TSE:CXF) and ImmunoPrecise Antibodies (CVE:IPA) are both small-cap manufacturing companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, community ranking, media sentiment, dividends, institutional ownership, valuation and profitability.

CI Canadian Convertible Bond ETF Common has higher earnings, but lower revenue than ImmunoPrecise Antibodies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CI Canadian Convertible Bond ETF CommonN/AN/AN/AN/AN/A
ImmunoPrecise AntibodiesC$19.47M8.33-C$22.19M-C$0.89-7.30

Company Net Margins Return on Equity Return on Assets
CI Canadian Convertible Bond ETF CommonN/A N/A N/A
ImmunoPrecise Antibodies N/A N/A N/A

In the previous week, CI Canadian Convertible Bond ETF Common's average media sentiment score of 0.00 equaled ImmunoPrecise Antibodies'average media sentiment score.

Company Overall Sentiment
CI Canadian Convertible Bond ETF Common Neutral
ImmunoPrecise Antibodies Neutral

ImmunoPrecise Antibodies received 29 more outperform votes than CI Canadian Convertible Bond ETF Common when rated by MarketBeat users. However, 57.89% of users gave CI Canadian Convertible Bond ETF Common an outperform vote while only 54.79% of users gave ImmunoPrecise Antibodies an outperform vote.

CompanyUnderperformOutperform
CI Canadian Convertible Bond ETF CommonOutperform Votes
11
57.89%
Underperform Votes
8
42.11%
ImmunoPrecise AntibodiesOutperform Votes
40
54.79%
Underperform Votes
33
45.21%

Summary

ImmunoPrecise Antibodies beats CI Canadian Convertible Bond ETF Common on 2 of the 3 factors compared between the two stocks.

Get CI Canadian Convertible Bond ETF Common News Delivered to You Automatically

Sign up to receive the latest news and ratings for CXF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CXF vs. The Competition

MetricCI Canadian Convertible Bond ETF CommonPharmaceutical Preparations IndustryManufacturing SectorTSE Exchange
Market CapC$49.79MC$6.70BC$2.04BC$5.66B
Dividend Yield4.84%3.16%2.73%6.45%
P/E RatioN/A7.2322.5929.08
Price / SalesN/A239.6858.58570.51
Price / CashN/A65.8551.7283.49
Price / BookN/A6.301.983.76
Net IncomeN/AC$143.17M-C$385.85MC$301.95M
7 Day Performance-2.09%7.61%3.47%3.35%
1 Month Performance-2.28%-1.90%-1.57%-0.31%
1 Year Performance3.25%-2.34%6.14%12.48%

CI Canadian Convertible Bond ETF Common Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CXF
CI Canadian Convertible Bond ETF Common
N/AC$9.85
-0.3%
N/A+3.2%C$49.79MN/A0.0090
IPA
ImmunoPrecise Antibodies
N/AC$6.50
+0.8%
N/A+0.0%C$162.08MC$19.47M-7.3080Gap Down
FRX
Fennec Pharmaceuticals
N/AC$7.08
-6.6%
N/AN/AC$136.54MC$34.86M-119.9310Negative News
Gap Down
APM
Andean Precious Metals
2.9305 of 5 stars
C$1.29
+7.5%
C$2.00
+55.0%
N/AC$135.47MC$154.78M2.5530News Coverage
ITH
International Tower Hill Mines
N/AC$0.91
-3.2%
N/A-1.1%C$127.76MN/A-38.02220News Coverage
Gap Up
GXE
Gear Energy
N/AN/AN/AN/AC$126.52MC$134.93M10.391,310
CRDL
Cardiol Therapeutics
N/AC$1.40
flat
N/A-39.2%C$116.17MN/A-2.7520
GPH
Graphite One
N/AC$0.92
+2.2%
N/A+19.5%C$93.15MN/A-13.2320Gap Up
MDNA
Medicenna Therapeutics
N/AC$1.10
+10.0%
N/A-56.6%C$82.30MC$4,868.39-3.0320Gap Up
EQ
EQ
N/AC$1.01
+1.0%
N/A-8.4%C$70.29MC$9.70M-15.0840
WMD
WeedMD
N/AC$0.28
-1.8%
N/A+0.0%C$67.82MC$27.53M-0.66628Gap Up

Related Companies and Tools


This page (TSE:CXF) was last updated on 4/28/2025 by MarketBeat.com Staff
From Our Partners